Drugmaker Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Travoprost Ophthalmic Solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback